coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Crawley Care Collaborative PCN, Crawley · Health Inequalities Profile

    PCN U52694 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    51,712

    Registered population

    64.6% aged 18–64

    13.1%

    Aged 65+

    ICB 21.9% · England 17.9%

    26.4%

    Ethnic minority (non-White)

    15.4% Asian · England 9.6%

    0.4%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~134

    Core20 residents (est.)

    Resident basis; registered basis ~129 · see page 3

    6,811

    Hypertension register

    +0.64% in 3 yrs · England +5.60%

    499

    SMI register

    39.1% of Crawley's

    871

    COPD register

    Reviews +25.06% in 3 yrs

    Forecast to 2030

    7,336

    Hypertension patients, 2030

    +525 on today

    77.9%

    QRISK ≥20% on statins, 2030

    +2.83pp over 3 yrs

    2.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    15
    Fifteen of twenty-five measures trail England's trend.

    Over 2023 to 2025, hypertension prevalence rose +0.6% (England +5.6%), stroke fell 2.4% (+2.3%) and dementia fell 19.5% (+6.0%), which may reflect unverified coding.

    82.1%
    Age-five booster and MMR2 miss 95.0% target.

    At age 5 in Q1 2025/26, 4-in-1 booster is 12.9 pp below the 95.0% target and MMR2 (86.1%) is 8.9 pp below, suggesting recall.

    71.9%
    Cardiovascular and SMI care exceed England averages.

    QRISK ≥ 20% lipid therapy reaches 71.9% (England 63.6%), SMI blood pressure checks reach 89.3% (83.4%) and under-80s hypertension control reaches 70.5% (67.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger list with 13.1% aged 65+ and 15.4% Asian residents may influence demand

    Across 51,712 registered patients, the PCN has a younger age profile: 13.1% are aged 65+ (Crawley 13.7%, NHS Sussex Integrated Care Board 21.9%, England 17.9%) and 22.4% are aged 0-17 (Crawley 22.1%, NHS Sussex Integrated Care Board 17.7%, England 19.6%). Census usual residents indicate a 26.4% ethnic minority share, including 15.4% Asian / Asian British residents (Crawley 15.4%, NHS Sussex Integrated Care Board 3.7%, England 9.6%), recorded at Leacroft Medical Practice (18.9%) and Southgate Medical Group (15.6%). Age figures use registered patients, whereas ethnicity reflects resident catchment populations.

    Age profile

    0–1722.4%
    18–6464.6%
    65+13.1%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White73.5%
    Asian15.4%
    Black4.4%
    Mixed4.0%
    Other2.7%

    Older people · falls rows are Crawley local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Crawley LA)2,5742,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)87.5%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.3%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Crawley LA)1,2059819552024/25
    Falls deaths, all ages, per 100,000 (Crawley LA)12.614.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 0.4% overall and concentrated within Southgate Medical Group

    The PCN Core20 cohort is 0.4%, below Crawley (1.3%), NHS Sussex Integrated Care Board (9.2%) and England (21.0%), while average IMD decile is 4.8 (England 5.5). Weighted practice share is 0.2% against the PCN's 0.4%, and resident estimates indicate 134 people. Southgate Medical Group records a 1.1% Core20 share (129 estimated patients), whereas Leacroft Medical Practice, Bridge Medical Centre and Langley Corner Surgery each record 0.0%. Recorded Core20 patients concentrate at Southgate Medical Group, indicating proactive outreach can focus on that practice.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Southgate Medical1.1% · 129 patients
    Leacroft Medical0.0% · 0 patients
    Bridge0.0% · 0 patients
    Langley Corner0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    499

    SMI register

    0.98% recorded prevalence

    497

    Learning disability register

    0.97% recorded prevalence

    23

    Care homes, 395 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Crawley, Census 2021

    The PCN records 497 learning disability patients (1.0% prevalence vs Crawley 0.8%, NHS Sussex Integrated Care Board 0.6%, England 0.6%) and 499 severe mental illness patients (1.0% vs Crawley 0.9%, NHS Sussex Integrated Care Board 1.1%, England 1.0%), alongside 23 catchment care homes with 395 beds. Crude register prevalence does not establish unmet need, and care home beds do not establish resident patient numbers.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks reached 89.3% and BMI checks 89.8%, exceeding England (83.4% and 82.1%). Smoking cessation offers fell 3.8 pp over 2023 to 2025 (England +0.1 pp) to 92.3% (England 94.2%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,811

    Hypertension register

    +0.64%

    Register growth, 3 yrs

    Crawley +6.33% · England +5.60%

    −0.92pp

    BP control, under 80

    ≤140/90 · +3.49pp aged 80+

    +525

    More patients by 2030

    Forecast 7,336 (13.49%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.3% (6,811 patients), below Crawley (13.8%), England (15.2%) and NHS Sussex Integrated Care Board (16.3%). Register growth over 2023 to 2025 rose +0.6% (+0.1 pp), trailing Crawley (+6.3%) and England (+5.6%), which may reflect a younger list (13.1% aged 65+ vs England 17.9%). An unadjusted benchmark scenario implies +348 to +1,065 patients. Recent blood pressure monitoring is 93.4% (England 90.0%). Under-80 blood pressure control (<= 140/90 mmHg) is 70.5% (England 67.8%), but slipped 0.9 pp over 2023 to 2025 while England rose +2.1 pp. Hypertension control leads national averages, but slower register growth and slipping younger-cohort control highlight an opportunity to strengthen opportunistic detection and systematic recall.

    Lipids and statins

    For QRISK >= 20%, lipid therapy is 71.9%, exceeding England (63.6%) and Crawley (65.9%). Primary statin coverage in diabetes is 74.1% (England 73.2%), but fell 1.5 pp over 2023 to 2025 (England +1.5 pp). Above-average lipid reach positions the PCN well, while slipping diabetic statin coverage warrants targeted recall.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202687,982£2.10£2.42£1.86£184,762
    Cardiovascular (all), 2025105,302£2.62£3.32£3.33£275,891

    In 2026, the PCN prescribed 87,982 lipid-modifying items at £2.10 per item (England £1.86, Crawley £2.34, NHS Sussex Integrated Care Board £2.42). Spend was £184,762, which is £21,116 more than at England's unit cost and £28,154 less than at the ICB rate. Unit-cost differences reflect local formulary choices and case-mix rather than an efficiency saving target.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +9.53%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.55%

    Asthma prevalence, PCN 3-yr % change

    COPD review coverage reached 74.6% (England 76.4%), up +25.1% over 2023 to 2025 (England +2.8%), while COPD prevalence stands at 1.7% (England 1.9%). Asthma reviews reached 67.4% (England 65.7%), rising +9.5% over 2023 to 2025 (England +4.4%), although asthma register prevalence fell 1.6% (England +0.5%) to 6.9%. Across the 3,272-patient asthma register, a scale estimate of 1,067 patients lacked a recorded annual review, with Bridge Medical Centre recording 51.0%.

    Cancer register and children's immunisation

    Cancer register prevalence is 2.8% (Crawley 3.2%, England 3.8%), rising +2.3% over 2023 to 2025 (England +9.0%). In childhood immunisations (Q1 2025/26), 24-month 6-in-1 coverage reached 96.0%, exceeding the 95.0% target by 1 pp. However, age-five coverage fell below the 95.0% target by 8.9 pp for MMR2 (86.1%) and by 12.9 pp for the 4-in-1 booster (82.1%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.0%

    England 91.0%

    6-in-1 complete primary course at 24 months96.0%

    England 92.2%

    MMR dose 1 at 24 months92.9%

    England 88.3%

    MMR dose 2 at age 586.1%

    England 82.8%

    4-in-1 pre-school booster at age 582.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022, 58.5% of staged cancers across NHS Sussex ICB were diagnosed at stage 1 or 2 (England 55.3%), below the 75.0% national ambition. Known-stage completeness was 64.3% (8,209 of 12,766 registered cancers; England 67.0%). Across the ICB, reaching 75.0% early diagnosis would require about 1,360 additional early-stage cases annually. Staging data reflects ICB registry figures, not PCN performance. At PCN level, cancer register growth of +2.3% over 2023 to 2025 (England +9.0%) may reflect a younger list but indicates a need to verify whether primary care case-finding and coding are keeping pace.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Surrey and Sussex Healthcare NHS Trust achieved 77.7% on the 28-day faster diagnosis standard (standard 75.0%), but reached 70.0% on the 62-day treatment standard (standard 85.0%). Comparatively, 62-day delivery was 86.8% at Epsom and St Helier University Hospitals NHS Trust, 71.5% across NHS Surrey and Sussex Integrated Care Board, 71.2% in England, and 65.2% at University Hospitals Sussex NHS Foundation Trust. Diagnostic 6-week waits at the trust reached 28.5% (England 23.1%), with cystoscopy at 43.1% and Magnetic Resonance Imaging at 27.5%. These figures reflect provider activity, not PCN performance.

    Pathways within standard (%)Surrey and Sussex HealthcareSussexEpsom and St HelierSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)77.7474.0189.7079.2979.32
    31-day treatment (96%)96.2076.7999.1690.4592.50
    62-day referral to treatment (85%)69.9765.2086.8271.5171.16
    Diagnostic waits over 6 weeks (%)Surrey and Sussex HealthcareSussexEpsom and St HelierEngland
    MRI27.535.620.3121.40
    CT18.498.571.069.92
    Echocardiography43.780.3925.4928.48
    Colonoscopy15.1139.3533.0130.83
    Gastroscopy21.0620.0230.9029.02
    All 15 DM01 tests28.5012.956.8323.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In June 2026 (provisional), community services data recorded 78,050 contacts for Crawley residents, with 56,740 contacts among adults aged 65 and over, representing 72.7% of activity. These borough-level resident figures indicate heavy elderly community care demand across the local system, though they do not represent PCN-specific delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Telephone access varies by 23.0 pp across practices while overall experience spans 6.4 pp

    Overall QOF achievement was 94.5% at Leacroft Medical Practice, whereas Southgate Medical Group achieved 97.7% (England 92.5%). Across captured practices, the range in QOF vaccination and immunisation-domain achievement is 17.0 pp. Bridge Medical Centre achieved 62.3%, whereas Southgate Medical Group achieved 79.3% (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Leacroft Medical940.076.4%76.8%84.2%
    Southgate Medical1001.156.1%64.0%79.5%
    Langley Corner1020.053.4%67.3%78.8%
    Bridge950.068.1%63.2%77.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCrawleyAssetPCNCrawley
    Care homes (catchment)23 (395 beds)n/aSchools (catchment)84n/a
    Children's centres77Places of worship5145
    Libraries22Food banks (VCS)1no data
    Homelessness support (VCS)0no dataDay centres (VCS)11
    Carers support groups (VCS)11Primary schools (LA maintained)1210
    Primary academies1314Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension case-finding and coding audit

    Recorded prevalence is 13.3% (6,811 patients) vs 13.8% in Crawley and 15.2% in England (+0.6% 3-year change vs +5.6% in England), giving an unadjusted scenario of +348 to +1,065 patients. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured annual asthma review recall

    Asthma review coverage is 67.4% (Crawley 68.7%, England 65.7%; 51.0% at Bridge Medical Centre), leaving a scale estimate of 1,067 patients without a recorded review across 3,272 patients. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Stroke and dementia register validation

    Stroke prevalence is 1.4% (729 patients; Crawley 1.5%, England 1.9%), a +31 to +248 scenario; dementia is 0.5% (278 patients; Crawley 0.4%, England 0.8%), a -51 to +127 scenario. For discussion: practices could audit discharge coding and care-home records to test whether register contractions reflect list turnover or missed diagnoses. Moderate effort to run.

    Evidence base: the stroke/TIA register is the cohort for AF anticoagulation and blood-pressure control (pre-stroke prevention) as well as hyperacute care; practices well below expected prevalence are the case-finding list, and the pre-stroke prevention gap concentrates in deprived practices.

    Policy anchor: Core20PLUS5 (CVD); NHS CVD ambitions to 2029.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted communication and engagement (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 clinical outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Targeted smoking cessation support (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case finding and recall (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer coding and register review (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Telephone access workflow review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension case-finding and coding audit (p12)Hypertension register · Hypertension: QOF prevalence · Aged 65+Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 3 · Stroke and dementia register validation (p12)Stroke register · Stroke: QOF prevalence · Dementia registerCore20PLUS5 CVD · CVDPREVENT · SSNAP · 66.7% diagnosis ambition · 95% care plan 2027PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15